Come up with a name for your new list and we'll add to it:
Odyssey Thera raised a round of funding on February 10, 2000. Investors include
Burrill & Company.
Odyssey Thera offers technology that measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables select…